Tata Elxsi has announced the launch of ViTel™, an advanced Material Intelligence solution specifically designed for medical device manufacturers. According to the latest announcement from PRNewswire, the solution was co-developed with Viridium AI, a material intelligence platform company. The product is being formally introduced at DeviceTalks Boston 2026, where Tata Elxsi is presenting its latest advances in AI-powered MedTech engineering and compliance. As reported by Tata Elxsi, ViTel™ is an AI-driven platform that helps medical device manufacturers manage complex material intelligence challenges across sourcing, engineering, quality control, compliance, and regulatory readiness.
Medical device manufacturers are facing increasing challenges related to supplier dependencies, sourcing risks, changing regulations, and country-of-origin requirements. As reported by Tata Elxsi, much of this critical information is often spread across BOMs, ERP systems, PLM systems, supplier documents, and internal teams, making compliance and risk analysis a time-consuming manual process. The company notes that critical product knowledge remains buried across these systems, making every new regulation or customer requirement a costly manual exercise. According to the latest announcement, material decisions now affect margin, resilience, product velocity, and market access, creating an urgent need for comprehensive material intelligence solutions.
ViTel™ addresses this challenge by creating a reusable Material Intelligence layer across the enterprise. The platform enables manufacturers to identify material and supplier dependencies, assess sourcing and country-of-origin exposure, evaluate alternative materials and suppliers, understand product and material risks impacting cost and continuity, and improve regulatory and compliance readiness. As reported by Tata Elxsi, the solution is powered by Viridium AI's Knowledge Cloud, Chemical Digital Twin, and science-constrained AI models, transforming fragmented enterprise data into a connected knowledge graph covering products, parts, chemicals, suppliers, regulations, and supporting evidence. The platform draws on Tata Elxsi's three decades of Med-Tech engineering and regulatory expertise, with this knowledge embedded into how the solution reasons about material risk, compliance, and sourcing decisions.
According to Tata Elxsi, ViTel™ integrates over three decades of MedTech engineering and regulatory expertise into the platform's intelligence engine. As reported by Viridium AI CEO Niraj Deo, the platform enables manufacturers to understand the 'material DNA' of their products, turning product and material intelligence into a reusable enterprise asset. The partnership combines Tata Elxsi's design-led and AI-first engineering, deep domain expertise, and access to global healthcare and medtech enterprises with Viridium AI's platform and technology innovation. ViTel™ has been co-developed through Tata Elxsi's STEP UP co-innovation initiative, which focuses on partnering with high-potential deep-tech companies to develop next-generation enterprise solutions.
According to Sreevatsa Sahasranaman, Senior Vice President and Head of Healthcare and Life Sciences at Tata Elxsi, ViTel™ helps enterprises make faster and more confident decisions across sourcing, engineering, quality, and compliance workflows. The launch comes at a time when healthcare and MedTech manufacturers are under increasing pressure to improve supply chain resilience, reduce compliance risks, and accelerate product development cycles. As reported by Tata Elxsi, AI-powered Material Intelligence platforms such as ViTel™ could play a critical role in helping medical device companies improve operational efficiency while ensuring regulatory compliance across global markets. Tata Elxsi brings design-led and AI-first engineering, deep domain expertise, and access to global healthcare and medtech enterprises, while Viridium AI contributes platform and technology innovation to the comprehensive solution.
